MINI FUTURE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Borsa Italiana 21:04:59 25/06/2024 BST | ||
| 15.29 EUR | 0.00% |
|
| Current month | +4.02% | ||
| 1 month | +5.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
Latest news about RECORDATI
More news
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 15.29 | -3.47% |
| 24/06/24 | 15.84 | +4.97% |
| 21/06/24 | 15.09 | +0.07% |
| 20/06/24 | 15.08 | +10.07% |
| 19/06/24 | 13.7 | -4.20% |
Real-time Borsa Italiana
Last update June 25, 2024 at 09:04 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
BNP Paribas
|
| P1IDV4 | |
| ISIN | NLBNPIT1IDV4 |
| Date issued | 19/10/2022 |
| Strike | 34.39 € |
| Maturity | 18/12/2025 (541 Days) |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.27 € |
|---|---|
| Lowest since issue | 3.22 € |
| Spread | 0.61 € |
| Spread % | 3.91% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.4
EUR
Average target price
52.64
EUR
Spread / Average Target
+6.56%
- Stock Market
- Certificates
- P1IDV4 Certificat
